A Treatment With Fulvestrant and Exemestane in Postmenopausal Patients With Advanced Hormone Receptor-Positive (HR) + Breast Cancer
Clinical trial NCT01171417 · COMPLETED
Trial details
- NCT number
- NCT01171417
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2010-08-01
- Primary completion
- 2013-11-01
- Enrollment
- 570
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.